Paul L. Ornstein

6.7k total citations
96 papers, 5.1k citations indexed

About

Paul L. Ornstein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Paul L. Ornstein has authored 96 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cellular and Molecular Neuroscience, 58 papers in Molecular Biology and 29 papers in Organic Chemistry. Recurrent topics in Paul L. Ornstein's work include Neuroscience and Neuropharmacology Research (54 papers), Receptor Mechanisms and Signaling (24 papers) and Ion channel regulation and function (15 papers). Paul L. Ornstein is often cited by papers focused on Neuroscience and Neuropharmacology Research (54 papers), Receptor Mechanisms and Signaling (24 papers) and Ion channel regulation and function (15 papers). Paul L. Ornstein collaborates with scholars based in United States, United Kingdom and Canada. Paul L. Ornstein's co-authors include David Lodge, Darryle D. Schoepp, David Bleakman, M. Brian Arnold, Graham L. Collingridge, Rebecca A. Wright, J. David Leander, Zuner A. Bortolotto, Vernon R. J. Clarke and Michael E. Jung and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Neuron.

In The Last Decade

Paul L. Ornstein

95 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul L. Ornstein United States	42	3.6k	2.6k	1.0k	865	493	96	5.1k
James A. Monn United States	38	5.0k 1.4×	3.4k 1.3×	541 0.5×	1.0k 1.2×	513 1.0×	101	6.2k
C. Bræstrup Denmark	30	4.2k 1.2×	2.6k 1.0×	678 0.6×	1.0k 1.2×	390 0.8×	55	5.8k
Elsebet Ø. Nielsen Denmark	34	2.5k 0.7×	2.6k 1.0×	801 0.8×	312 0.4×	418 0.8×	85	4.5k
Bryan G. Johnson United States	33	3.8k 1.1×	2.8k 1.1×	377 0.4×	728 0.8×	261 0.5×	59	4.6k
Bjarke Ebert Denmark	37	2.7k 0.8×	1.9k 0.7×	473 0.5×	773 0.9×	409 0.8×	125	4.5k
Tage Honoré Denmark	23	4.1k 1.2×	2.9k 1.1×	354 0.3×	609 0.7×	447 0.9×	43	5.1k
Richard F. Squires United States	30	4.1k 1.2×	2.6k 1.0×	541 0.5×	934 1.1×	427 0.9×	60	5.8k
Peter D. Suzdak Denmark	36	4.0k 1.1×	2.6k 1.0×	305 0.3×	598 0.7×	458 0.9×	87	5.2k
Erik H.F. Wong United States	40	4.9k 1.4×	3.7k 1.4×	561 0.5×	857 1.0×	668 1.4×	91	6.9k
Vincent Mutel Switzerland	38	3.3k 0.9×	2.8k 1.1×	307 0.3×	612 0.7×	366 0.7×	85	4.6k

Countries citing papers authored by Paul L. Ornstein

Since Specialization

Citations

This map shows the geographic impact of Paul L. Ornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Ornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Ornstein more than expected).

Fields of papers citing papers by Paul L. Ornstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Ornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Ornstein. The network helps show where Paul L. Ornstein may publish in the future.

Co-authorship network of co-authors of Paul L. Ornstein

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Ornstein. A scholar is included among the top collaborators of Paul L. Ornstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Ornstein. Paul L. Ornstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Carrie K., Andrew Alt, Ann Marie L. Ogden, et al.. (2006). Antiallodynic and Antihyperalgesic Effects of Selective Competitive GLUK5 (GluR5) Ionotropic Glutamate Receptor Antagonists in the Capsaicin and Carrageenan Models in Rats. Journal of Pharmacology and Experimental Therapeutics. 319(1). 396–404. 27 indexed citations

Ramadan, NM, SD Silberstein, KW Johnson, et al.. (2004). LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine. Cephalalgia. 24(7). 596–602. 138 indexed citations

Lauri, Sari E., Zuner A. Bortolotto, Robert Nisticò, et al.. (2003). A Role for Ca2+ Stores in Kainate Receptor-Dependent Synaptic Facilitation and LTP at Mossy Fiber Synapses in the Hippocampus. Neuron. 39(2). 327–341. 159 indexed citations

Smolders, Ilse, Zuner A. Bortolotto, Vernon R. J. Clarke, et al.. (2002). Antagonists of GLUK5-containing kainate receptors prevent pilocarpine-induced limbic seizures. Nature Neuroscience. 5(8). 796–804. 124 indexed citations

Lauri, Sari E., et al.. (2001). Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fibre synapses.. Neuropharmacology. 41(8). 907–915. 63 indexed citations

Lauri, Sari E., Zuner A. Bortolotto, David Bleakman, et al.. (2001). A Critical Role of a Facilitatory Presynaptic Kainate Receptor in Mossy Fiber LTP. Neuron. 32(4). 697–709. 162 indexed citations

O’Neill, Michael J., Caroline Hicks, Ann Bond, et al.. (2000). LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia. Neuropharmacology. 39(9). 1575–1588. 51 indexed citations

Bortolotto, Zuner A., Vernon R. J. Clarke, Michael C. Parry, et al.. (1999). Kainate receptors are involved in synaptic plasticity. Nature. 402(6759). 297–301. 265 indexed citations

Bleakman, David, et al.. (1999). Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons. European Journal of Pharmacology. 378(3). 331–337. 38 indexed citations

10.

Ornstein, Paul L., et al.. (1998). Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 8(4). 389–394. 16 indexed citations

11.

Houghton, Andrea K., E. S. Louise Faber, Boris A. Chizh, et al.. (1998). Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology. 37(10-11). 1287–1297. 48 indexed citations

12.

Simmons, Rosa Maria A., et al.. (1998). Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology. 37(1). 25–36. 137 indexed citations

13.

O’Neill, Michael J., Ann Bond, Paul L. Ornstein, et al.. (1998). Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology. 37(10-11). 1211–1222. 93 indexed citations

14.

Schoepp, Darryle D., Craig R. Salhoff, Kimberly S. Fuson, et al.. (1996). Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) and its racemate (LY215490). Journal of Neural Transmission. 103(8-9). 905–916. 10 indexed citations

15.

Schoepp, Darryle D., et al.. (1996). Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.. Molecular Pharmacology. 49(4). 581–585. 91 indexed citations

16.

Ornstein, Paul L., M. Brian Arnold, J. David Leander, et al.. (1995). (3SR,4aRS,6SR,8aRS)-6-(1H-Tetrazol-5-yl)decahydroisoquinoline-3-carboxylic Acid, a Novel, Competitive, Systemically Active NMDA and AMPA Receptor Antagonist. Journal of Medicinal Chemistry. 38(25). 4885–4890. 16 indexed citations

17.

Schoepp, Darryle D., David Lodge, David Bleakman, et al.. (1995). In vitro and in vivo antagonism of AMPA receptor activation by (3s,4ar,6r,8ar)-6-[2-(1(2)h-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid. Neuropharmacology. 34(9). 1159–1168. 59 indexed citations

18.

McQuaid, Loretta A., Edward C. Smith, Charles H. Mitch, et al.. (1992). Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones. Journal of Medicinal Chemistry. 35(18). 3319–3324. 50 indexed citations

19.

Ornstein, Paul L., Darryle D. Schoepp, M. Brian Arnold, et al.. (1992). 6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists. Journal of Medicinal Chemistry. 35(19). 3547–3560. 25 indexed citations

20.

Schoepp, Darryle D., et al.. (1989). CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo. Journal of Neural Transmission. 78(3). 183–193. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact